{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:46:11Z","timestamp":1793997971558,"version":"4.8.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["522004005"],"award-info":[{"award-number":["522004005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with hematological cancers (HC) are at high risk of infections, in particular community-acquired pneumonia (CAP). Recent data on incidence and predictors of CAP among patients with HC are scarce.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a cohort study (2016\u20132019) in 2 hospitals in the Netherlands among adults with HC to calculate incidence rates (IRs) of CAP. In addition, we performed a nested case-control study to identify predictors of CAP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 275 CAP cases during 6264 patient-years of follow-up. The IR of CAP was 4390\/100\u00a0000 patient-years of follow-up. Compared with the general population, IR ratios ranged from 5.4 to 55.3 for the different HCs. The case fatality and intensive care unit (ICU) admission rates were 5.5% and 9.8%, respectively. Predictors for CAP in patients with HC were male sex, anemia, lymphocytopenia, chronic kidney disease, cardiovascular disease, autologous and allogeneic stem cell transplantation, treatment with immunosuppressive medication for graft-vs-host disease, treatment with rituximab in the past year, and treatment with immunomodulators (lenalidomide, thalidomide, pomalidomide and\/or methotrexate) in the past month. Independent predictors of a severe disease course (death or ICU admission) included neutropenia (odds ratio, 4.14 [95% confidence interval, 1.63\u201310.2]), pneumococcal pneumonia (10.24 [3.48\u201330.1]), chronic obstructive pulmonary disease (6.90 [2.07\u201323.0]), and the use of antibacterial prophylaxis (2.53 [1.05\u20136.08]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The burden of CAP in patients with HC is high, with significant morbidity and mortality rates. Therefore, vaccination against respiratory pathogens early in the disease course is recommended, in particular before starting certain immunosuppressive therapies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac005","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T20:10:07Z","timestamp":1641327007000},"page":"1046-1053","source":"Crossref","is-referenced-by-count":18,"title":["Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019"],"prefix":"10.1093","volume":"75","author":[{"given":"Maria","family":"Certan","sequence":"first","affiliation":[{"name":"Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases , Amsterdam Universitair Medische Centra, Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8481-5455","authenticated-orcid":false,"given":"Hannah M","family":"Garcia Garrido","sequence":"additional","affiliation":[{"name":"Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases , Amsterdam Universitair Medische Centra, Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases , Amsterdam Universitair Medische Centra, Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarom","family":"Heijmans","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam Universitair Medische Centra , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P","family":"Grobusch","sequence":"additional","affiliation":[{"name":"Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases , Amsterdam Universitair Medische Centra, Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Goorhuis","sequence":"additional","affiliation":[{"name":"Centre of Tropical Medicine and Travel Medicine, Department of Infectious Diseases , Amsterdam Universitair Medische Centra, Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"2022092921005395100_CIT0001","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients.","volume":"68","author":"Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022092921005395100_CIT0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12913-018-3861-8","article-title":"Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.","volume":"19","author":"Schmedt","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2022092921005395100_CIT0003","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"2022092921005395100_CIT0004","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijid.2021.03.072","article-title":"Invasive pneumococcal disease among adults with hematological and solid organ malignancies.","volume":"106","author":"Garcia Garrido","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2022092921005395100_CIT0005","first-page":"148","article-title":"Impact of rituximab (Rituxan) on the treatment of B-cell non-Hodgkin\u2019s lymphoma.","volume":"35","author":"Dotan","year":"2010","journal-title":"P T"},{"key":"2022092921005395100_CIT0006","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/10428194.2017.1347931","article-title":"Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.","volume":"59","author":"Williams","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"2022092921005395100_CIT0007","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies.","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"key":"2022092921005395100_CIT0008","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","article-title":"Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia.","volume":"192","author":"Claessens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2022092921005395100_CIT0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bmt.2009.255","article-title":"Background to hematopoietic cell transplantation, including post transplant immune recovery.","volume":"44","author":"Mackall","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2022092921005395100_CIT0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"key":"2022092921005395100_CIT0011","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma.","volume":"138","author":"Pratt","year":"2007","journal-title":"Br J Haematol"},{"key":"2022092921005395100_CIT0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciz728","article-title":"Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus-infected individuals in a high-income setting.","volume":"71","author":"Garcia Garrido","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022092921005395100_CIT0013","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.12-0210","article-title":"Pneumococcal pneumonia: mechanisms of infection and resolution.","volume":"142","author":"Dockrell","year":"2012","journal-title":"Chest"},{"key":"2022092921005395100_CIT0014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states.","volume":"378","author":"Di Sabatino","year":"2011","journal-title":"Lancet"},{"key":"2022092921005395100_CIT0015","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022092921005395100_CIT0016","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/S1473-3099(18)30601-7","article-title":"Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).","volume":"19","author":"Mikulska","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022092921005395100_CIT0017","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged &gt;\/=2 years: an open-label study.","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022092921005395100_CIT0018","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/21645515.2018.1436424","article-title":"Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.","volume":"14","author":"Lindstrom","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2022092921005395100_CIT0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2019.10.006","article-title":"Clinical effectiveness of conjugate pneumococcal vaccination in hematopoietic stem cell transplantation recipients.","volume":"26","author":"Roberts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022092921005395100_CIT0020","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar3047","article-title":"Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.","volume":"12","author":"Rehnberg","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2022092921005395100_CIT0021","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.vaccine.2021.07.004","article-title":"A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.","volume":"39","author":"Klein","year":"2021 7","journal-title":"Vaccine"},{"key":"2022092921005395100_CIT0022","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1684\/bdc.2010.1079","article-title":"Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single center.","volume":"97","author":"Lachenal","year":"2010","journal-title":"Bull Cancer"},{"key":"2022092921005395100_CIT0023","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.medmal.2019.11.006","article-title":"Observational study of vaccination in cancer patients: how can vaccine coverage be improved?","volume":"50","author":"Monier","year":"2020","journal-title":"Med Mal Infect"},{"key":"2022092921005395100_CIT0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/21645515.2019.1632683","article-title":"Uptake of 13-valent pneumococcal conjugate vaccine among US adults aged 19 to 64 years with immunocompromising conditions.","volume":"16","author":"Vietri","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"2022092921005395100_CIT0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCP.0000000000000156","article-title":"Pneumonia in the neutropenic cancer patient.","volume":"21","author":"Evans","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2022092921005395100_CIT0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/annonc\/mdu192","article-title":"Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).","volume":"26","author":"Maschmeyer","year":"2015","journal-title":"Ann Oncol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac005\/42588141\/ciac005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1046\/46205147\/ciac005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1046\/46205147\/ciac005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:06:47Z","timestamp":1664485607000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/6\/1046\/6535024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,2,23]]},"published-print":{"date-parts":[[2022,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac005","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,15]]},"published":{"date-parts":[[2022,2,23]]}}}